Profile
David E.
Redlick served as Chairman at Hale & Dorr LLP and Co-Chairman at Life-Sciences Group NV.
He was a Partner at Wilmer Cutler Pickering Hale & Dorr LLP.
He also served as Lead Independent Director at IVERIC bio, Inc. from 2017 to 2019.
Redlick received his graduate degree from Harvard University in 1975 and his undergraduate degree from the University of Wisconsin in 1972.
Former positions of David E. Redlick
| Companies | Position | End |
|---|---|---|
| IVERIC BIO, INC. | Director/Board Member | 2019-10-06 |
| Life-Sciences Group NV | Chairman | - |
| Hale & Dorr LLP | Chairman | - |
Wilmer Cutler Pickering Hale & Dorr LLP
 Wilmer Cutler Pickering Hale & Dorr LLP Miscellaneous Commercial ServicesCommercial Services Wilmer Cutler Pickering Hale & Dorr LLP provides legal services. It specializes in trial, appellate, securities, regulatory, intellectual property, corporate transactions, bankruptcy, environmental, labor and employment, private client, real estate and tax matters. The company was founded in 1918 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Training of David E. Redlick
| Harvard University | Graduate Degree |
| University of Wisconsin | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Wilmer Cutler Pickering Hale & Dorr LLP
Wilmer Cutler Pickering Hale & Dorr LLP Miscellaneous Commercial ServicesCommercial Services Wilmer Cutler Pickering Hale & Dorr LLP provides legal services. It specializes in trial, appellate, securities, regulatory, intellectual property, corporate transactions, bankruptcy, environmental, labor and employment, private client, real estate and tax matters. The company was founded in 1918 and is headquartered in Boston, MA. | Commercial Services |
| Hale & Dorr LLP | Commercial Services |
IVERIC bio, Inc.
 IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
| Life-Sciences Group NV |
- Stock Market
- Insiders
- David E. Redlick
